Achieving Blood Pressure Control Through Enhanced Discharge (AchieveBP)

December 21, 2020 updated by: Julie Gleason-Comstock, Wayne State University
The primary aim of the study is to determine if enhanced discharge from the emergency department will improve blood pressure control and self-care management. Enhanced discharge will include a hypertension intervention delivered by a touch-screen kiosk over a three month period.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A targeted sample of patients with uncontrolled blood pressure at the time of their emergency department visit discharge will be randomized into either standard or enhanced discharge. To control for medication effects in achieving blood pressure control, both groups will receive similar blood pressure medication while actively participating in the study.

Study Type

Interventional

Enrollment (Actual)

139

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Detroit, Michigan, United States, 48201
        • Detroit Receiving Hospital Emergency Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 89 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Present with uncontrolled blood pressure to the emergency department (>140/90 for non-diabetics and >130/80 for diabetics)
  • Self-reported history of hypertension

Exclusion Criteria:

  • End-stage renal disease
  • No history of hypertension
  • Do not present with uncontrolled blood pressure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Enhanced discharge
Patient education about hypertension delivered through a touch-screen kiosk at 4 time points in addition to standard discharge.
Patient education on hypertension delivered through a touchscreen kiosk.
No Intervention: Standard discharge
Standard discharge is patient instruction, instructions for follow-up to primary care and medication/prescription

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Pressure (Systolic) at 180 Days
Time Frame: 180 days
Systolic Blood Pressure (SDB) at 180 days post-discharge
180 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Activation Measure (PAM)
Time Frame: Baseline
Measure of how actively involved patient is in their medical care.
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emergency Department Visitation Rate
Time Frame: Baseline to 180 days
Emergency department visits related to hypertension
Baseline to 180 days
Cost Effectiveness
Time Frame: 180 days
180 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Phillip D Levy, MD, Wayne State University
  • Principal Investigator: Julie A Gleason-Comstock, PhD, Wayne State University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

February 19, 2014

First Submitted That Met QC Criteria

February 20, 2014

First Posted (Estimate)

February 21, 2014

Study Record Updates

Last Update Posted (Actual)

December 22, 2020

Last Update Submitted That Met QC Criteria

December 21, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BCBSMF 1956.11

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Patient education

3
Subscribe